01 April 2004
Bradykinin-induced alterations of insulin-receptor interaction in rat adipose tissue under normo- and hypothermic conditions
Magdalena Gibas, Teresa Torlińska, Edyta Mądry, Paweł MaćkowiakMed Sci Monit 2004; 10(4): BR109-114 :: ID: 11627
Abstract
Background:In this study we compared the effect of bradykinin (BK) on insulin-receptor interaction in rat adipose plasma membranes under normothermic and hypothermic conditions.
Material/Methods: Plasma membranes were prepared and purified according to Havrankova and binding assay was performed using ([sup]125[/sup]I) – insulin. The kinetic parameters of the hormone-receptor interaction were analyzed according to Scatchard using the LIGAND – Pc v.3.1 computer program. Additionally, we determined blood glucose and insulin concentrations. The results were interpreted statistically according to one-way analysis of variance (ANOVA).Results: Statistically significant changes mainly involved the low-affinity receptor class. In normothermic rats, BK provoked a decrease in insulin-receptor affinity (expressed as a drop in the association constant Ka2 by 64% and enhancement in the dissociation constant Kd2 by 215%), which was compensated by a 188% increase in the number of insulin receptors. Therefore, association constant times binding capacity remained unchanged. Administration of BK resulted in a decrease in serum glucose concentration by about 50%, while the insulin level did not change. Hypothermia lowered insulin concentration by 68% and elevated both the value of the association constant times binding capacity by 166% and the insulin-receptor affinity (Kd2 decreased by 71% and Ka2 increased markedly by about 771%). Administration of BK to hypothermic rats elevated blood insulin level by 180% and diminished (by about 64%) the value of association constant times binding capacity.Conclusions: The results indicate that bradykinin plays a significant role in carbohydrate metabolism and may influence insulin-receptor interaction under both normothermic and hypothermic conditions.
Keywords: Adipose Tissue - drug effects, Adipose Tissue - metabolism, Bradykinin - pharmacology, Cell Membrane - drug effects, Cell Membrane - metabolism, Hypothermia, Induced, Insulin - metabolism, Rats, Wistar, Receptor, Insulin - metabolism, Adipose Tissue - metabolism, Bradykinin - pharmacology, Cell Membrane - metabolism, Hypothermia, Induced, Insulin - metabolism, Rats, Wistar, Receptor, Insulin - metabolism
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952